… clinical Stage I non-small cell carcinoma of the lung treated with … with Stage I non-small cell
lung cancer were treated with … pathologic diagnosis of non-small cell lung cancer and were …

… Lung cancer is the leading cause of cancer mortality and non-small cell lung cancer (NSCLC)
accounts for more than 85% of all lung cancers. Platinum-based doublet chemotherapy is …

… We examined the recent changes in stage distribution in newly diagnosed patients with
non-small cell lung cancer (NSCLC) using a national database to assess the impact of recent …

… Tyrosine kinase inhibitors and immunotherapy for lung cancer are the two major areas …
as chimeric antigen receptor T cell for non-small cell lung cancer attempting to provide insights …

… cause of cancer death, non-small cell lung cancer (NSCLC) [1, 2]. Less than a quarter of
lung … Lung squamous cell carcinoma (LUSC) has no approved targeted therapies and few …

… classify lung cancer histologies, distinguish primary tumours from metastases to the lung from
other … between patients with resected non-small-cell lung cancer who had poor prognosis (…

… Most information on results with radiotherapy (RT) for stage I non-small cell lung cancer (…
A literature search for studies on stage I non-small cell lung carcinoma (NSCLC) treated by …

… Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens
for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 …

… lung cancer patients, and extrathoracic metastases are found in 49%. In patients with non-small
cell lung cancer (… For patients with small cell lung cancer (SCLC), both types of patients …

… commonly mutated in multiple cancer types. This report describes the feasibility and
diagnostic yield of this assay in 381 consecutive patients with non–small cell lung cancer (NSCLC). …